Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes
Open Access
- 1 December 2020
- Vol. 23 (12) , 101863
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA221813, R01DK120866, RO1HL118808, RO1HL124366)
- National Cancer Institute (P30 CA016059)
- Virginia Commonwealth University
- Center for Clinical and Translational Research
This publication has 78 references indexed in Scilit:
- A unifying model for mTORC1-mediated regulation of mRNA translationNature, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathwayBasic Research in Cardiology, 2012
- Lymphangioleiomyomatosis (LAM): Molecular insights lead to targeted therapiesRespiratory Medicine, 2010
- MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas LigandJournal of Biological Chemistry, 2010
- Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathwayCardiovascular Research, 2009
- Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2009
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialThe Lancet, 2008
- Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stressCardiovascular Research, 2008
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004